Long-term results of combined-modality therapy in resectable non-small-cell lung cancer
Carcinoma, Non-Small-Cell Lung
Although pathologic complete response outside the protocol setting is low, survival of this large patient cohort is comparable to that of patients in published combined-modality trials. Survival is significantly influenced by patient age, complete resection, pathologic stage, and pneumonectomy. These results can help guide standard clinical practice and emphasize the need for novel induction regimens.